Literature DB >> 12704122

Epitope-specific humoral immunity to Plasmodium vivax Duffy binding protein.

Jia Xainli1, Jennifer L Cole-Tobian, Moses Baisor, Will Kastens, Moses Bockarie, Syed Shams Yazdani, Chetan E Chitnis, John H Adams, Christopher L King.   

Abstract

Erythrocyte invasion by Plasmodium vivax is completely dependent on binding to the Duffy blood group antigen by the parasite Duffy binding protein (DBP). The receptor-binding domain of this protein lies within a cysteine-rich region referred to as region II (DBPII). To examine whether antibody responses to DBP correlate with age-acquired immunity to P. vivax, antibodies to recombinant DBP (rDBP) were measured in 551 individuals residing in a village endemic for P. vivax in Papua New Guinea, and linear epitopes mapped in the critical binding region of DBPII. Antibody levels to rDBP(II) increased with age. Four dominant linear epitopes were identified, and the number of linear epitopes recognized by semi-immune individuals increased with age, suggesting greater recognition with repeated infection. Some individuals had antibodies to rDBP(II) but not to the linear epitopes, indicating the presence of conformational epitopes. This occurred in younger individuals or subjects acutely infected for the first time with P. vivax, indicating that repeated infection is required for recognition of linear epitopes. All four dominant B-cell epitopes contained polymorphic residues, three of which showed variant-specific serologic responses in over 10% of subjects examined. In conclusion, these results demonstrate age-dependent and variant-specific antibody responses to DBPII and implicate this molecule in partial acquired immunity to P. vivax in populations in endemic areas.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12704122      PMCID: PMC153250          DOI: 10.1128/IAI.71.5.2508-2515.2003

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  23 in total

1.  Biochemical, biophysical, and functional characterization of bacterially expressed and refolded receptor binding domain of Plasmodium vivax duffy-binding protein.

Authors:  S Singh; K Pandey; R Chattopadhayay; S S Yazdani; A Lynn; A Bharadwaj; A Ranjan; C Chitnis
Journal:  J Biol Chem       Date:  2001-03-13       Impact factor: 5.157

2.  Mapping regions containing binding residues within functional domains of Plasmodium vivax and Plasmodium knowlesi erythrocyte-binding proteins.

Authors:  A Ranjan; C E Chitnis
Journal:  Proc Natl Acad Sci U S A       Date:  1999-11-23       Impact factor: 11.205

3.  Antibodies raised against receptor-binding domain of Plasmodium knowlesi Duffy binding protein inhibit erythrocyte invasion.

Authors:  Agam P Singh; Sunil K Puri; Chetan E Chitnis
Journal:  Mol Biochem Parasitol       Date:  2002-04-30       Impact factor: 1.759

Review 4.  The neglected burden of Plasmodium vivax malaria.

Authors:  K Mendis; B J Sina; P Marchesini; R Carter
Journal:  Am J Trop Med Hyg       Date:  2001 Jan-Feb       Impact factor: 2.345

Review 5.  Host cell invasion by malaria parasites.

Authors:  C E Chitnis; M J Blackman
Journal:  Parasitol Today       Date:  2000-10

6.  Serologic responses to recombinant Plasmodium vivax Duffy binding protein in a Colombian village.

Authors:  P A Michon; M Arevalo-Herrera; T Fraser; S Herrera; J H Adams
Journal:  Am J Trop Med Hyg       Date:  1998-10       Impact factor: 2.345

7.  The erythrocyte binding motif of plasmodium vivax duffy binding protein is highly polymorphic and functionally conserved in isolates from Papua New Guinea.

Authors:  J Xainli; J H Adams; C L King
Journal:  Mol Biochem Parasitol       Date:  2000-12       Impact factor: 1.759

8.  Low CD4(+) T cell responses to the C-terminal region of the malaria merozoite surface protein-1 may be attributed to processing within distinct MHC class II pathways.

Authors:  S J Quin; E M Seixas; C A Cross; M Berg; V Lindo; B Stockinger; J Langhorne
Journal:  Eur J Immunol       Date:  2001-01       Impact factor: 5.532

9.  Evolutionary relationships of conserved cysteine-rich motifs in adhesive molecules of malaria parasites.

Authors:  Pascal Michon; Jamie R Stevens; Osamu Kaneko; John H Adams
Journal:  Mol Biol Evol       Date:  2002-07       Impact factor: 16.240

10.  Age-acquired immunity to a Plasmodium vivax invasion ligand, the duffy binding protein.

Authors:  Jennifer L Cole-Tobian; Alfred Cortés; Moses Baisor; Will Kastens; Jia Xainli; Moses Bockarie; John H Adams; Christopher L King
Journal:  J Infect Dis       Date:  2002-07-26       Impact factor: 5.226

View more
  32 in total

1.  Antibody responses and avidity of naturally acquired anti-Plasmodium vivax Duffy binding protein (PvDBP) antibodies in individuals from an area with unstable malaria transmission.

Authors:  Sedigheh Zakeri; Laleh Babaeekhou; Akram Abouie Mehrizi; Maryam Abbasi; Navid Dinparast Djadid
Journal:  Am J Trop Med Hyg       Date:  2011-06       Impact factor: 2.345

2.  Strain-specific duffy binding protein antibodies correlate with protection against infection with homologous compared to heterologous plasmodium vivax strains in Papua New Guinean children.

Authors:  Jennifer L Cole-Tobian; Pascal Michon; Moses Biasor; Jack S Richards; James G Beeson; Ivo Mueller; Christopher L King
Journal:  Infect Immun       Date:  2009-06-29       Impact factor: 3.441

3.  Identification and Characterization of Functional Human Monoclonal Antibodies to Plasmodium vivax Duffy-Binding Protein.

Authors:  Lenore L Carias; Sebastien Dechavanne; Vanessa C Nicolete; Sokunthea Sreng; Seila Suon; Chanaki Amaratunga; Rick M Fairhurst; Celia Dechavanne; Samantha Barnes; Benoit Witkowski; Jean Popovici; Camille Roesch; Edwin Chen; Marcelo U Ferreira; Niraj H Tolia; John H Adams; Christopher L King
Journal:  J Immunol       Date:  2019-04-03       Impact factor: 5.422

4.  Conserved and variant epitopes of Plasmodium vivax Duffy binding protein as targets of inhibitory monoclonal antibodies.

Authors:  Francis B Ntumngia; Jesse Schloegel; Samantha J Barnes; Amy M McHenry; Sanjay Singh; Christopher L King; John H Adams
Journal:  Infect Immun       Date:  2012-01-03       Impact factor: 3.441

5.  Mapping epitopes of the Plasmodium vivax Duffy binding protein with naturally acquired inhibitory antibodies.

Authors:  Patchanee Chootong; Francis B Ntumngia; Kelley M VanBuskirk; Jia Xainli; Jennifer L Cole-Tobian; Christopher O Campbell; Tresa S Fraser; Christopher L King; John H Adams
Journal:  Infect Immun       Date:  2009-12-14       Impact factor: 3.441

Review 6.  Finding the sweet spots of inhibition: understanding the targets of a functional antibody against Plasmodium vivax Duffy binding protein.

Authors:  Francis B Ntumngia; Christopher L King; John H Adams
Journal:  Int J Parasitol       Date:  2012-10-12       Impact factor: 3.981

7.  Immunogenicity of a synthetic vaccine based on Plasmodium vivax Duffy binding protein region II.

Authors:  Francis B Ntumngia; Samantha J Barnes; Amy M McHenry; Miriam T George; Jesse Schloegel; John H Adams
Journal:  Clin Vaccine Immunol       Date:  2014-06-25

8.  Duffy Blood Group System and the malaria adaptation process in humans.

Authors:  Gledson Barbosa de Carvalho; Glauber Barbosa de Carvalho
Journal:  Rev Bras Hematol Hemoter       Date:  2011

Review 9.  Plasmodium vivax: who cares?

Authors:  Mary R Galinski; John W Barnwell
Journal:  Malar J       Date:  2008-12-11       Impact factor: 2.979

10.  Naturally-acquired humoral immune responses against the N- and C-termini of the Plasmodium vivax MSP1 protein in endemic regions of Brazil and Papua New Guinea using a multiplex assay.

Authors:  Carmen Fernandez-Becerra; Sergi Sanz; Marina Brucet; Danielle I Stanisic; Fabiana P Alves; Erney P Camargo; Pedro L Alonso; Ivo Mueller; Hernando A del Portillo
Journal:  Malar J       Date:  2010-01-21       Impact factor: 2.979

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.